02/09/2026
PAPER SPOTLIGHT | Can E7 protein detection add useful information after an HPV-positive result?
The PIPAVIR study evaluated high-risk HPV E7 protein detection as a potential triage approach for referral to colposcopy. The researchers examined E7 assays alongside HPV genotyping and cytology in a cross-sectional screening evaluation.
Why is this study worth reading?
• It separates viral-presence testing from functional biomarker testing.
• It asks whether E7 information could contribute to an HPV-positive triage pathway.
• It illustrates why assay, population and clinical endpoint must always be specified when interpreting biomarker evidence.
Important boundary: the study evaluated different E7 assays. Its findings should not be interpreted as clinical-performance evidence for E7 GENPRO.
Read the publication: https://pubmed.ncbi.nlm.nih.gov/28470689/